Recently added

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols

Ursino, Moreno; Dimairo, Munyaradzi; Solovyeva, Olga; Ashby, Deborah; Villacampa Javierre, Guillermo; Rekowski, Jan (Elsevier, 2025-01)

Precision Oncology: A Global Perspective on Implementation and Policy Development

Horgan, Denis; Tanner, Marcel; AGGARWAL, CHARU; Thomas, David; Grover, Surbhi; Basel-Salmon, Lina; Dienstmann, Rodrigo (American Society of Clinical Oncology, 2025-01-23)

Prognostic significance of mutation type and chromosome fragility in Fanconi anemia

Ramírez de Haro, María José; Pujol, Roser; Minguillón, Jordi; Bogliolo, Massimo; Persico, Ilaria; Cavero, Debora; Carrasco Lopez, Estela; Diaz de Heredia, Cristina (Wiley, 2025-02)

Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)

Pfeiler, Georg; Hlauschek, Dominik; Mayer, Erica; Lambertini, Matteo; Agostinetto, Elisa; de Azambuja, Evandro; Bellet Ezquerra, Meritxell (Elsevier, 2025-01)

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]

DeMichele, Angela; Dueck, Amylou C.; Martín Jiménez, Miguel; Burstein, Harold; Pfeiler, Georg; Hlauschek, Dominik; Bellet Ezquerra, Meritxell (BMC, 2025-01-23)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols

Precision Oncology: A Global Perspective on Implementation and Policy Development

Prognostic significance of mutation type and chromosome fragility in Fanconi anemia

Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols ﻿

Precision Oncology: A Global Perspective on Implementation and Policy Development ﻿

Prognostic significance of mutation type and chromosome fragility in Fanconi anemia ﻿

Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109) ﻿

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13] ﻿

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols

Precision Oncology: A Global Perspective on Implementation and Policy Development

Prognostic significance of mutation type and chromosome fragility in Fanconi anemia

Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]